| Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils IK Campbell, S Miescher, DR Branch, PJ Mott, AH Lazarus, D Han, ... The Journal of Immunology 192 (11), 5031-5038, 2014 | 146 | 2014 |
| Engineered human tmpk/AZT as a novel enzyme/prodrug axis for suicide gene therapy T Sato, A Neschadim, M Konrad, DH Fowler, A Lavie, JA Medin Molecular Therapy 15 (5), 962-970, 2007 | 132 | 2007 |
| Analog of H2 relaxin exhibits antagonistic properties and impairs prostate tumor growth JD Silvertown, JC Symes, A Neschadim, T Nonaka, JCH Kao, ... The FASEB Journal 21 (3), 754-765, 2007 | 70 | 2007 |
| A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation A Neschadim, JA McCart, A Keating, JA Medin Biology of Blood and Marrow Transplantation 13 (12), 1407-1416, 2007 | 66 | 2007 |
| A new pyrimidine-specific reporter gene: a mutated human deoxycytidine kinase suitable for PET during treatment with acycloguanosine-based cytotoxic drugs Y Likar, J Zurita, K Dobrenkov, L Shenker, S Cai, A Neschadim, JA Medin, ... Journal of Nuclear Medicine 51 (9), 1395-1403, 2010 | 59 | 2010 |
| Autologous transplantation of Lentivector/acid ceramidase–transduced hematopoietic cells in nonhuman Primates JS Walia, A Neschadim, O Lopez-Perez, A Alayoubi, X Fan, S Carpentier, ... Human gene therapy 22 (6), 679-687, 2011 | 42 | 2011 |
| Relaxin-3 and receptors in the human and rhesus brain and reproductive tissues JD Silvertown, A Neschadim, HN Liu, P Shannon, JS Walia, JCH Kao, ... Regulatory peptides 159 (1-3), 44-53, 2010 | 36 | 2010 |
| Bystander killing of malignant cells via the delivery of engineered thymidine-active deoxycytidine kinase for suicide gene therapy of cancer A Neschadim, JCM Wang, A Lavie, JA Medin Cancer Gene Therapy 19 (5), 320-327, 2012 | 34 | 2012 |
| The engineered thymidylate kinase (TMPK)/AZT enzyme-prodrug axis offers efficient bystander cell killing for suicide gene therapy of cancer T Sato, A Neschadim, A Lavie, T Yanagisawa, JA Medin PLoS One 8 (10), e78711, 2013 | 33 | 2013 |
| Extracellular histones identified in crocodile blood inhibit in-vitro HIV-1 infection HN Kozlowski, ETL Lai, PC Havugimana, C White, A Emili, D Sakac, ... Aids 30 (13), 2043-2052, 2016 | 29 | 2016 |
| Targeting the relaxin hormonal pathway in prostate cancer A Neschadim, AJS Summerlee, JD Silvertown International Journal of Cancer 137 (10), 2287-2295, 2015 | 28 | 2015 |
| Structure–activity relationships of pyrazole derivatives as potential therapeutics for immune thrombocytopenias MK Purohit, SK Chakka, I Scovell, A Neschadim, AM Bello, N Salum, ... Bioorganic & Medicinal Chemistry 22 (9), 2739-2752, 2014 | 26 | 2014 |
| Cell fate control gene therapy based on engineered variants of human deoxycytidine kinase A Neschadim, JCM Wang, T Sato, DH Fowler, A Lavie, JA Medin Molecular Therapy 20 (5), 1002-1013, 2012 | 25 | 2012 |
| Cytokine profiles in mouse models of experimental immune thrombocytopenia reveal a lack of inflammation and differences in response to intravenous immunoglobulin depending on … D Leontyev, A Neschadim, DR Branch Transfusion 54 (11), 2871-2879, 2014 | 22 | 2014 |
| Relaxin receptor antagonist AT-001 synergizes with docetaxel in androgen-independent prostate xenografts A Neschadim, LB Pritzker, KPH Pritzker, DR Branch, AJS Summerlee, ... Endocrine-Related Cancer 21 (3), 459-471, 2014 | 22 | 2014 |
| Disulfide linked pyrazole derivatives inhibit phagocytosis of opsonized blood cells MK Purohit, I Scovell, A Neschadim, Y Katsman, DR Branch, LP Kotra Bioorganic & medicinal chemistry letters 23 (8), 2324-2327, 2013 | 20 | 2013 |
| Mouse models for immune‐mediated platelet destruction or immune thrombocytopenia (ITP) A Neschadim, DR Branch Current protocols in immunology 113 (1), 15.30. 1-15.30. 13, 2016 | 19 | 2016 |
| Mouse models of autoimmune diseases: immune thrombocytopenia A Neschadim, D R Branch Current pharmaceutical design 21 (18), 2487-2497, 2015 | 18 | 2015 |
| Engineered human Tmpk fused with truncated cell-surface markers: versatile cell-fate control safety cassettes M Scaife, N Pacienza, BCY Au, JCM Wang, S Devine, E Scheid, CJ Lee, ... Gene Therapy 20 (1), 24-34, 2013 | 18 | 2013 |
| c-SRC protein tyrosine kinase regulates early HIV-1 infection post-entry SDS McCarthy, D Sakac, A Neschadim, DR Branch Aids 30 (6), 849-858, 2016 | 16 | 2016 |
Branch DRCanadian Blood Services/University of TorontoAdresse e-mail validée de utoronto.ca
